Can High Plasma Ceruloplasmin Levels Cause Acquired Activated Protein C Resistance?

Thromb Haemost 1998; 79(02): 449-450
DOI: 10.1055/s-0037-1615013

Scientific and Standardization Committee Communication

Schattauer GmbH

L. Ripoll

¹Angio-Hematology, Hospital Lariboisière, Paris

,

E. Mazoyer

¹Angio-Hematology, Hospital Lariboisière, Paris

,

B. Baudin

²Biochemistry, Hospital Saint-Antoine, Paris

,

S. Lacam

¹Angio-Hematology, Hospital Lariboisière, Paris

,

B. Varsat

³Centre Examens de Santé, CPAM, Paris, France

,

L. O. Drouet

¹Angio-Hematology, Hospital Lariboisière, Paris

References
1 Dahlbäck B, Svensson PJ. Familial thrombophilia due to a previously unrec ognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
2 Bertina RM, Koster T, Rosendaal FT, Dirven RJ, de Ronde H, van der Velden PP, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
3 Green D, Maliekel K, Sushko E, Akhtar R, Soff GA. Activated protein C resistance in cancer patients. Thromb Haemost 1998; Suppl: 316.
4 Cumming TR, Fildes S, Yoong A, Keeney S, Hay CRM. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995; 90: 725-7.
5 Olivieri O, Manzato F, Guella A, Bernardi F, Lunghi B, Girelli D, Azzini M, Brocco G, Russi C, Corrocher R. Resistance to activated protein C in healthy women taking oral contraceptives. Br J Haematol 1995; 91: 465-70.
6 Walker FJ, Fay PJ. Characterization of an interaction between protein C and ceruloplasmin. J Biol Chem 1990; 265: 1834-6.
7 Ripoll L, Paulin D, Thomas S, Drouet LO. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene. Thromb Haemost 1998; 78: 960-1.
8 Yang F, Cupples RL, Bonifacio MJ, Sanford JA, Horton WA, Bowman BH. Human Ceruloplasmin. J Biol Chem 1990; 265: 10780-5.